Quick Search:

uzh logo
Browse by:
bullet
bullet
bullet
bullet

Zurich Open Repository and Archive 

Permanent URL to this publication: http://dx.doi.org/10.5167/uzh-43789

Stupp, R; Hegi, M E; Neyns, B; Goldbrunner, R; Schlegel, U; Clement, P M J; Grabenbauer, G G; Ochsenbein, A F; Simon, M; Dietrich, P Y; Pietsch, T; Hicking, C; Tonn, J C; Diserens, A C; Pica, A; Hermisson, M; Krueger, S; Picard, M; Weller, M (2010). Reply to M.C. Chamberlain. Journal of Clinical Oncology, 28(33):e696-e697.

[img]PDF (Verlags-PDF) - Registered users only
1075Kb

Item Type:Journal Article, refereed, further contribution
Communities & Collections:04 Faculty of Medicine > University Hospital Zurich > Clinic for Neurology
DDC:610 Medicine & health
Language:Italian
Date:2010
Deposited On:28 Jan 2011 18:19
Last Modified:27 Nov 2013 23:38
Publisher:American Society of Clinical Oncology
ISSN:0732-183X
Additional Information:Reply to: Chamberlain, M C. What role should cilengitide have in the treatment of glioblastoma? J Clin Oncol. 2010 Nov 20;28(33):e695
Free access at:PubMed ID. An embargo period may apply.
Publisher DOI:10.1200/JCO.2010.31.2843
Citations:Web of Science®
Google Scholar™

Users (please log in): suggest update or correction for this item

Repository Staff Only: item control page